FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11065111000001109: Arlevert tablets (Ashbourne Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
39880501000001118 Arlevert tablets (Ashbourne Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110937901000001119 Arlevert tablets (Hennig Arzneimittel GmbH & Co. KG) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Is a Dimenhydrinate 40mg / Cinnarizine 20mg tablets true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Has active ingredient Dimenhydrinate true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Has active ingredient Cinnarizine true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Is a Arlevert true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Has specific active ingredient Dimenhydrinate true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Has specific active ingredient Cinnarizine true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) 100 tablet 4 x 25 tablets Is pack of False Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Arlevert tablets (Ashbourne Pharmaceuticals Ltd) 100 tablet 4 x 25 tablets Has AMP True Arlevert tablets (Ashbourne Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start